UB Paderborn / Katalog / Suche / in CDI

1 – 10 von 10

Sortiert nach

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870)

Clinical cancer research, 2017-12, Vol.23 (23), p.7199-7208

2017

Link zum Volltext

Verfügbarkeit prüfen

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

Cancer, 2002-02, Vol.94 (S4), p.1349-1357

2002

Link zum Volltext

Verfügbarkeit prüfen

Sentinel node biopsy in breast cancer

Annals of surgical oncology, 1998-03, Vol.5 (2), p.126-130

1998

Link zum Volltext

Verfügbarkeit prüfen

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2705-2711

2014

Link zum Volltext

Verfügbarkeit prüfen

Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules

Journal of hematology and oncology, 2008-09, Vol.1 (1), p.13-13, Article 13

2008

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis Mimicking Metastatic Breast Cancer

The breast journal, 2011-09, Vol.17 (5), p.533-535

2011

Link zum Volltext

Verfügbarkeit prüfen

Mammographic and Clinical Predictors of Drainage Patterns in Breast Lymphoscintigrams Obtained During Sentinel Node Procedures

Clinical nuclear medicine, 2003-07, Vol.28 (7), p.558-564

2003

Link zum Volltext

Verfügbarkeit prüfen

Accelerated Bone Mineral Density Loss Occurs with Similar Incidence and Severity, But with Different Risk Factors, after Autologous versus Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2010-08, Vol.16 (8), p.1130-1137

2010

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy of Non-Hodgkin's Lymphoma with 90Y-DOTA Humanized Anti-CD22 IgG (90Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?

The Journal of nuclear medicine (1978), 2003-12, Vol.44 (12), p.2000-2018

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 10 von 10

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(10)

Sprache

Englisch
(10)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(10)
Female
(9)
Aged
(8)
Middle Aged
(8)
Life Sciences & Biomedicine
(7)
Science & Technology
(7)
Male
(6)
Oncology
(6)
Aged, 80 And Over
(4)
Prognosis
(4)
Adolescent
(3)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biological And Medical Sciences
(3)
Breast Neoplasms - Pathology
(3)
Medical Sciences
(3)
Positron-Emission Tomography - Methods
(3)
Radionuclide Imaging
(3)
Radiopharmaceuticals
(3)
Young Adult
(3)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870)

Radiation dosimetry results for zevalin radioimmunotherapy of rituximab‐refractory non‐hodgkin lymphoma

Sentinel node biopsy in breast cancer

In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma

Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules

Sarcoidosis Mimicking Metastatic Breast Cancer

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

Mammographic and Clinical Predictors of Drainage Patterns in Breast Lymphoscintigrams Obtained During Sentinel Node Procedures

Accelerated Bone Mineral Density Loss Occurs with Similar Incidence and Severity, But with Different Risk Factors, after Autologous versus Allogeneic Hematopoietic Cell Transplantation

Radioimmunotherapy of Non-Hodgkin's Lymphoma with 90Y-DOTA Humanized Anti-CD22 IgG (90Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?

Aktive Filter

Suchergebnisse filtern